Tickerplace logo

Tickerplace

Glaukos Corporation logo

GKOSGlaukos Corporation

GKOS Stock Price, Valuation & Chart | Glaukos Corporation

Compare
$164.84-0.76 (-0.46%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Medical - Devices
OverviewFinancialsDividendsRatios

GKOS Historical price chart

GKOS Key Stats

Market Capitalization9.72B
PE Ratio-191.6
EPS-0.86
Trading Volume985.41K
Today's High/Low167.28/163.13
Dividend Yield0.00
52 Week High/Low191.62/73.16
Shares Outstanding58.98M
GKOS Financial Statement
GKOS Analyst ratings
GKOS Analysis & performance metrics

GKOS Company profile

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal…

GKOS Management team

Management
Alex R. ThurmanCFO
Senior Vice President & Chief Financial Officer
Tomas Navratil Ph.D.
Chief Development Officer
Jane E. Rady
Senior Vice President of Corporate Strategy & Business Development
Diana A. Scherer
Vice President of Compliance & Deputy General Counsel
L. Jay Katz FACS, M.D.
Chief Medical Officer
Michele M. Allegretto
Senior Vice President of Human Resources
Thomas William BurnsCEO
Chairman & Chief Executive Officer
Joseph E. GilliamCOO
President & Chief Operating Officer
Total 8 executives

GKOS Frequently asked questions

What is Glaukos Corporation (GKOS) Stock Price?

Current stock price of Glaukos Corporation (GKOS) stock is $164.84. The stock price is -0.46% lower in the session. The intraday range can be seen from this page. Volume of Glaukos Corporation (GKOS) stock is 985.41K.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Glaukos Corporation (GKOS) stock price going up or down today?

The stock price of Glaukos Corporation (GKOS) can change with earnings, company news, and overall market sentiment. Glaukos Corporation operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Glaukos Corporation stock expensive at its current price?

Whether Glaukos Corporation looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for GKOS on this page is -191.67. EPS on this page is -0.86. Compare those figures with peers and growth expectations before deciding if the current Glaukos Corporation price is justified.

How has the stock price of Glaukos Corporation (GKOS) performed historically?

Historical performance for Glaukos Corporation (GKOS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how GKOS reacted to past earnings and market events.

Should I buy Glaukos Corporation (GKOS) stock, at this price?

Buying Glaukos Corporation (GKOS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.